Search for: "State v. Lilly" Results 1 - 20 of 710
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 May 2016, 7:25 am by Daily Record Staff
Criminal law — Sufficiency of the evidence — Use of handgun in commission of crime On October 5, 2005, a jury in the Circuit Court for Baltimore City convicted appellant Marcus James Lilly of first-degree assault, use of a handgun in the commission of a crime of violence, and possession of a regulated firearm. [read post]
23 Nov 2009, 9:59 pm
By Donald Zuhn -- With oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
25 Jun 2019, 9:28 am
Even after being questioned about this at the hearing, Lilly did not state that the PCT-application contained a mistake or omission and that this was clear to third parties. [read post]
28 Feb 2013, 6:01 am
  Given Genentech's history of actively litigating this family of patents (see, e.g., MedImmune, Inc. v. [read post]
1 Aug 2011, 8:19 am
According to the Indianapolis Business Journal, the drug generated $577 million in sales for Lilly last year.The case is Eli Lilly & Co. v. [read post]
23 Sep 2010, 9:37 pm by Patent Docs
Noonan -- The Washington Legal Foundation (WLF), a self-styled "non-profit public interest law and policy center that regularly appears before federal and state courts to promote economic liberty, free enterprise, and a limited and accountable government," filed an amicus curiae brief on September 8th, urging the Federal Circuit to rehear en banc Eli Lilly's appeal of the Court's affirmance of an invalidity finding of U.S. [read post]
19 Apr 2016, 7:43 am by Gene Quinn
Recently, a group of amici led by Eli Lilly filed an amici curiae brief with the United States Supreme Court in the matter of Sequenom, Inc. v. [read post]
10 Apr 2019, 8:00 am by Overhauser Law Offices, LLC
Eli Lilly claims that it is the assignee of the ‘209 patent, a method patent which was upheld as valid by the Federal Circuit in, Eli Lilly and Company v. [read post]
7 Nov 2011, 12:06 pm
The IBJ quoted a Lilly statement as stating "Human Genome Sciences seek to foreclose a whole area of research in a way that is not only harmful to the industry, but would ultimately and unjustifiably hinder the future development of new medicines." [read post]
12 Jun 2013, 1:53 pm
Patent No. 8,419,307) ·         Count V for Patent Infringement (Inducement to Infringe U.S. [read post]
11 Jan 2013, 4:00 am by Paula Bremner
(Eli Lilly v Novopharm 2011 FC 1288; aff’d by bench 2012 FCA 232, appeal pending to SCC). [read post]